ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 117 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,463,000 | +50.1% | 80,175 | 0.0% | 0.13% | +29.3% |
| Q1 2020 | $2,307,000 | -39.7% | 80,175 | +32.8% | 0.10% | -23.3% |
| Q4 2019 | $3,828,000 | +125.0% | 60,352 | +0.0% | 0.13% | +111.5% |
| Q3 2019 | $1,701,000 | +6.4% | 60,350 | 0.0% | 0.06% | +10.9% |
| Q2 2019 | $1,599,000 | +23.8% | 60,350 | -14.2% | 0.06% | +25.0% |
| Q1 2019 | $1,292,000 | +48.0% | 70,350 | 0.0% | 0.04% | +29.4% |
| Q4 2018 | $873,000 | -24.5% | 70,350 | +16.6% | 0.03% | -15.0% |
| Q3 2018 | $1,157,000 | +32.2% | 60,350 | -6.2% | 0.04% | +21.2% |
| Q2 2018 | $875,000 | +98.9% | 64,350 | +5.5% | 0.03% | +94.1% |
| Q1 2018 | $440,000 | +95.6% | 61,000 | 0.0% | 0.02% | +88.9% |
| Q4 2017 | $225,000 | -14.8% | 61,000 | 0.0% | 0.01% | -18.2% |
| Q3 2017 | $264,000 | +166.7% | 61,000 | 0.0% | 0.01% | +175.0% |
| Q2 2017 | $99,000 | -10.8% | 61,000 | +1.7% | 0.00% | -33.3% |
| Q1 2017 | $111,000 | +16.8% | 60,000 | -1.6% | 0.01% | +20.0% |
| Q4 2016 | $95,000 | -78.8% | 61,000 | 0.0% | 0.01% | -79.2% |
| Q3 2016 | $448,000 | +38.3% | 61,000 | 0.0% | 0.02% | +33.3% |
| Q2 2016 | $324,000 | – | 61,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |